Abstract Purpose 2-[18 F] FDG PET/CT is of utmost importance for radiation treatment (RT)
planning and response monitoring in lung cancer patients, in both non-small and small cell …

Non‐small cell lung cancer (NSCLC) accounts for approximately one in five cancer‐related
deaths, and management requires increasingly complex decision making by health care …

Multidisciplinary team is beneficial to select an appropriate treatment plan for a patient with
lung cancer, where the collected cognitive evaluation information may be uncertain and …

This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were …

There are considerable disparities between the quality of cancer care and clinical outcomes
for cancer patients in different European countries, regions, hospitals and communities …

Lung cancer (LC) is the second most commonly diagnosed cancer and the primary cause of
cancer death worldwide in 2020. LC treatment is associated with huge costs for patients and …

Integrating clinical and pathological data together with imaging-derived information, such as
radiomics and sarcopenia status, creating new combined biomarkers that increase the …

Abstract Studies with [68 Ga] Ga-labeled or [18 F] F-labeled fibroblast activation protein
inhibitor compounds have demonstrated favorable characteristics for PET/CT imaging …

Multidisciplinary care is needed to decide the best therapeutic approach and to provide
optimal care to patients with lung cancer (LC). Multidisciplinary teams (MDTs) are optimal …

The management of patients with cancer is complex and requires contribution from a range
of healthcare professionals working alongside specialist oncology consultants to address …